NCT00840632View on ClinicalTrials.gov

Trandolapril 4 mg Tablet Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Healthy
Interventions
DRUG

Trandolapril 4 mg Tablets

1 x 4 mg, single-dose fasting

DRUG

Mavik® 4 mg Tablets

1 x 4 mg, single-dose fasting

Trial Locations (1)

M1L 4S4

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840632 - Trandolapril 4 mg Tablet Under Fasting Conditions | Biotech Hunter | Biotech Hunter